FDA grants accelerated approval for PTC’s AADC deficiency gene therapy
KEBILIDI is delivered via a precise neurosurgical procedure to the putamen of the brain.
Cytiva Pipe dream to pipeline WP 3
Autolus secures FDA approval for CAR-T cell therapy use in ALL
FDA delays priority review of Neurotech’s eye cell therapy implant
Mustang Bio’s MB-108 receives FDA orphan drug status for glioma treatment
NLS and Kadimastem stocks soar following merger agreement
FDA grants ODD to Modalis’ MDL-101 to treat LAMA2-CMD
Lyell goes all in on CAR-T therapies, buys ImmPACT Bio and trims pipeline
Dyno and Roche collaborate on neurological gene therapies
